Norway’s melanoma burden keeps climbing in older adults
Norway’s melanoma incidence continues to rise, but the pattern is no longer uniform across the population. A nationwide cohort analysis of cancer registry data from 1980 through 2024 found persistent growth in overall incidence, driven largely by older adults, while younger generations have begun to show stable or declining trends. The split is clinically important because it suggests prevention efforts have started to bend the curve for some age groups without yet reversing the long-term burden carried by people born earlier.
The study drew on first primary melanoma diagnoses recorded in the national Cancer Registry and followed secular patterns across sex, age, region, anatomical site, and subtype. Age-standardized rates were calculated against the European Standard Population 2013, and joinpoint regression quantified average annual percentage changes. Age-period-cohort modeling added another layer, making it possible to separate what changed over time from what was carried forward across generations.
Among 60,722 people with melanoma, 29,775 were male, accounting for 49.0% of the cohort. Overall incidence rose by roughly 2.4% to 2.7% per year over the full 1980 to 2024 period in both sexes. In practical terms, this is not a small drift in background risk; it is a sustained population-level increase that has accumulated over decades and remains visible in contemporary registry data.
Older birth cohorts are carrying most of the excess risk
The clearest signal came from age and birth-cohort analyses. Incidence remained stable or declined among younger individuals, yet it continued to rise by more than 5% annually in the oldest groups, reaching 5.2% to 6.6% depending on the subgroup. The age-period-cohort model pointed to a strong birth-cohort effect, with progressively increasing incidence across successive older birth cohorts. Younger cohorts, by contrast, showed stable or declining incidence.
That pattern fits a lifetime-exposure model of cutaneous melanoma. Melanoma risk is shaped by cumulative ultraviolet radiation exposure, intense intermittent sun exposure, and behavioral norms established early in life and carried forward for decades. Older cohorts in Norway likely experienced a different sun-exposure environment, different recreational habits, and less effective early-life sun protection than younger generations. Once those exposures are “locked in,” incidence can continue to surface many years later even if prevention improves for people born more recently.
A single sentence captures the central tension in the dataset: the epidemic is easing in the young, but it is still expanding in the old.
Regional variation points to unequal exposure patterns
Geography also mattered. Northern Norway recorded the largest regional increases, with an average annual percentage change of 4.6% in men and 3.1% in women. Regional differences of this kind rarely arise by chance alone. They often reflect a mix of latitude-related ultraviolet exposure, behavioral variation, occupational patterns, travel habits, skin phototypes, and differences in healthcare access or diagnostic intensity.
The authors also found sex-specific anatomic patterns. Incidence increased particularly on the head and neck in men, while the trunk and upper limbs showed the strongest rise in women. Those distributions are biologically and behaviorally plausible. Sun exposure is not random; it is patterned by clothing, outdoor work, recreation, and grooming practices. Men’s head and neck exposure may reflect less consistent photoprotection in a region where cumulative exposure matters, while women’s trunk and upper-limb patterns may mirror intermittent exposure, indoor tanning history, or seasonal clothing habits that leave those sites vulnerable.
These anatomical shifts are useful to clinicians because they help identify where vigilance should be highest during skin examination. They also signal that prevention cannot be generic. A population strategy that treats all body sites and all behaviors as equivalent will miss where risk is concentrating.
Superficial spreading melanoma remained the dominant rising subtype
Across histologic subtypes, superficial spreading melanoma showed the strongest increase, with average annual percentage changes of 4.1% in one sex group and 3.1% in the other. The subtype matters because it is the most common form of cutaneous melanoma and is closely linked to intermittent ultraviolet exposure. A persistent rise in this subtype reinforces the role of modifiable environmental exposure rather than a purely diagnostic artifact.
The subtype signal also argues against complacency. If improved awareness and earlier diagnosis were the only forces at work, one would expect a more uniform flattening across subtypes and ages. Instead, the data show a concentrated pattern of continued increase where lifetime UV-related behavior has had the most time to accumulate. The result is a registry picture that looks less like a broad plateau and more like a shifting epidemic with distinct age and regional contours.
Prevention now needs to be age-targeted, not generic
The interpretation is straightforward even if the underlying drivers are complex: melanoma incidence in Norway is still rising, but the growth is increasingly concentrated in older adults and in specific regions and anatomic sites. That means broad public health messaging alone is unlikely to be sufficient. Prevention will need to be targeted toward groups with persistently rising incidence, especially older men and women in higher-risk regions, while also preserving the gains already visible in younger cohorts.
For dermatology and primary care, the findings support continued skin surveillance in older adults, with attention to sex-specific exposure patterns and to body sites where incidence is increasing most quickly. For public health planners, the cohort effect suggests that earlier prevention may already be changing the trajectory in younger generations, which is encouraging, but the full benefit will take years to appear in national incidence curves.
The study has one final clinical implication: melanoma control is a long game. A prevention strategy that reduces ultraviolet exposure today may not show its full effect for decades, because the disease continues to surface in the cohorts that were exposed long before current messaging, sunscreen use, and sun-safety campaigns became routine.